The effects of resveratrol and selected metabolites on the radiation and antioxidant response

Cancer Biology and Therapy

Volumn 12, Issue 10, 2011, Pages 915-923

  Fabre, Kristin M ^a   Saito, Keita ^a   DeGraff, William ^a   Sowers, Anastasia L ^a   Thetford, Angela ^a   Cook, John A ^a   Krishna, Murali C ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antioxidants; Ionizing radiation; Oxidative stress; Peroxide; Piceatannol; Quinones; Resveratrol

Indexed keywords

3,4',5 TRIMETHOXYSTILBENE; DRUG METABOLITE; HYDROGEN PEROXIDE; PICEATANNOL; PTEROSTILBENE; RESVERATROL; RESVERATROL 3 O BETA DEXTRO GLUCURONIDE; RESVERATROL 3 SULFATE; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CYCLE S PHASE; CELL KILLING; CELL PROTECTION; CELL SURVIVAL; CLONOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG FIBROBLAST; MOUSE; NONHUMAN; OXIDATION; RADIATION PROTECTION; WHOLE BODY RADIATION;

ANIMALS; ANTIOXIDANTS; CELL CYCLE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDETIC ACID; FEMALE; FIBROBLASTS; HUMANS; HYDROGEN PEROXIDE; MICE; MICE, INBRED C3H; OXIDATIVE STRESS; PHENOLS; QUINONES; RADIATION-PROTECTIVE AGENTS; STILBENES; TERT-BUTYLHYDROPEROXIDE; WHOLE-BODY IRRADIATION;

EID: 81555210941     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.10.17714     Document Type: Article

References (50)

1. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 2011; 711:915-923; PMID: 21216256; http://dx.doi.org/10.1016/j.mrfmmm.2010.12.016
2. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010; 15:360-71; PMID:20413641; http://dx.doi.org/10.1634/ theoncologist.2009-S104
3. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5:493-506; PMID:16732220; http://dx.doi.org/10.1038/nrd2060
4. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, et al. Human, rat, and mouse metabolism of resveratrol. Pharm Res 2002; 19:1907-14; PMID:12523673; http://dx.doi.org/10.1023/A:1021414129280
5. Delmas D, Aires V, Limagne E, Dutartre P, Mazue F, Ghiringhelli F, et al. Transport, stability, and biological activity of resveratrol. Ann N Y Acad Sci 2011; 1215:48-59; PMID:21261641; http://dx.doi.org/10.1111/j.1749-6632.2010. 05871.x
6. Gagliano N, Aldini G, Colombo G, Rossi R, Colombo R, Gioia M, et al. The potential of resveratrol against human gliomas. Anticancer Drugs 2010; 21:140-50; PMID:20010425; http://dx.doi.org/10.1097/CAD.0b013e32833498f1
7. Kraft TE, Parisotto D, Schempp C, Efferth T. Fighting cancer with red wine? Molecular mechanisms of resveratrol. Crit Rev Food Sci Nutr 2009; 49:782-99; PMID:20443159; http://dx.doi.org/10.1080/10408390802248627
8. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, et al. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 2003; 309:1017-26; PMID:13679076; http://dx.doi.org/10.1016/j.bbrc.2003.08.105
9. Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, Khuri FR, et al. Cancer prevention with natural compounds. Semin Oncol 2010; 37:258-81; PMID:20709209; http://dx.doi.org/10.1053/j.seminoncol.2010.06.014
10. Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, et al. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett 2002; 175:165-73; PMID:11741744; http://dx.doi.org/10.1016/S0304-3835(01)00719-4
11. Baatout S, Derradji H, Jacquet P, Ooms D, Michaux A, Mergeay M. Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol. Int J Mol Med 2004; 13:895-902; PMID:15138632
12. Baatout S, Derradji H, Jacquet P, Mergeay M. Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma. Int J Mol Med 2005; 15:337-52; PMID:15647852
13. Fiore M, Festa F, Cornetta T, Ricordy R, Cozzi R. Resveratrol affects X-ray induced apoptosis and cell cycle delay in human cells in vitro. Int J Mol Med 2005; 15:1005-12; PMID:15870907
14. Kao CL, Huang PI, Tsai PH, Tsai ML, Lo JF, Lee YY, et al. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int J Radiat Oncol Biol Phys 2009; 74:219-28; PMID:19362240; http://dx.doi.org/10.1016/j.ijrobp.2008.12. 035
15. Scarlatti F, Sala G, Ricci C, Maioli C, Milani F, Minella M, et al. Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Cancer Lett 2007; 253:124-30; PMID:17321671; http://dx.doi.org/10.1016/j.canlet.2007.01.014
16. Johnson GE, Ivanov VN, Hei TK. Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis 2008; 13:790-802; PMID:18454317; http://dx.doi.org/10.1007/s10495-008-0212-y
17. Velioǧlu-Oǧünç A, Sehirli O, Toklu HZ, Ozyurt H, Mayadagli A, Eksioglu-Demiralp E, et al. Resveratrol protects against irradiation-induced hepatic and ileal damage via its anti-oxidative activity. Free Radic Res 2009; 43:1060-71; PMID:19707923; http://dx.doi.org/10.1080/ 10715760903171100
18. Carsten RE, Bachand AM, Bailey SM, Ullrich RL. Resveratrol reduces radiation-induced chromosome aberration frequencies in mouse bone marrow cells. Radiat Res 2008; 169:633-8; PMID:18494544; http://dx.doi.org/10.1667/RR1190.1
19. Ye K, Ji CB, Lu XW, Ni YH, Gao CL, Chen XH, et al. Resveratrol attenuates radiation damage in Caenorhabditis elegans by preventing oxidative stress. J Radiat Res (Tokyo) 2010; 51:473-9; PMID:20679743; http://dx.doi.org/10.1269/jrr. 10009
20. Murias M, Jager W, Handler N, Erker T, Horvath Z, Szekeres T, et al. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem Pharmacol 2005; 69: 903-12; PMID:15748702; http://dx.doi.org/10.1016/j.bcp.2004.12.001
21. Ovesná Z, Kozics K, Bader Y, Saiko P, Handler N, Erker T, et al. Antioxidant activity of resveratrol, piceatannol and 3,3′,4,4′,5, 5′-hexahydroxy-trans-stilbene in three leukemia cell lines. Oncol Rep 2006; 16:617-24; PMID:16865264
22. Samuni AM, Chuang EY, Krishna MC, Stein W, DeGraff W, Russo A, et al. Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants. Proc Natl Acad Sci USA 2003; 100:5390-5; PMID:12702779; http://dx.doi.org/10.1073/pnas. 0930078100
23. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins 2006.
24. Munro TR. The relative radiosensitivity of the nucleus and cytoplasm of Chinese hamster fibroblasts. Radiat Res 1970; 42:451-70; PMID:5463516; http://dx.doi.org/10.2307/3572962
25. Ward JF. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol 1988; 35:95-125; PMID:3065826; http://dx.doi.org/10.1016/S0079-6603(08) 60611-X
26. Cornforth MN, Bedford JS. A quantitative comparison of potentially lethal damage repair and the rejoining of interphase chromosome breaks in low passage normal human fibroblasts. Radiat Res 1987; 111:385-405; PMID:3659275; http://dx.doi.org/10.2307/3576926
27. Hosseinimehr SJ. Trends in the development of radioprotective agents. Drug Discov Today 2007; 12:794-805; PMID:17933679; http://dx.doi.org/10.1016/j. drudis.2007.07.017
28. Rasey JS, Nelson NJ, Mahler P, Anderson K, Krohn KA, Menard T. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution. Radiat Res 1984; 97:598-607; PMID:6328565; http://dx.doi.org/10.2307/3576151
29. Patt HM, Tyree EB, Straube RL, Smith DE. Cysteine Protection against X Irradiation. Science 1949; 110: 213-4; PMID:17811258; http://dx.doi.org/10.1126/ science.110.2852.213
30. Mitchell JB, Krishna MC. Nitroxides as radiation protectors. Mil Med 2002; 167:49-50; PMID:11873514
31. Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 1994; 65:27-33; PMID:7905906; http://dx.doi.org/10.1080/09553009414550041
32. Ostashevsky JY. A model relating cell survival to DNA fragment loss and unrepaired double-strand breaks. Radiat Res 1989; 118:437-66; PMID:2727270; http://dx.doi.org/10.2307/3577405
33. Kovacic P, Somanathan R. Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety. Oxid Med Cell Longev 2010; 3:86-100; PMID:20716933; http://dx.doi.org/10.4161/oxim.3.2. 11147
34. Quincozes-Santos A, Andreazza AC, Goncalves CA, Gottfried C. Actions of redox-active compound resveratrol under hydrogen peroxide insult in C6 astroglial cells. Toxicol In Vitro 2010; 24:916-20; PMID: 19945524; http://dx.doi.org/10.1016/j.tiv.2009.11.016
35. Leroy C, Mann C, Marsolier MC. Silent repair accounts for cell cycle specificity in the signaling of oxidative DNA lesions. EMBO J 2001; 20:2896-906; PMID:11387222; http://dx.doi.org/10.1093/emboj/20.11.2896
36. Frankenberg-Schwager M, Becker M, Garg I, Pralle E, Wolf H, Frankenberg D. The role of nonhomologous DNA end joining, conservative homologous recombination, and single-strand annealing in the cell cycledependent repair of DNA double-strand breaks induced by H(2)O(2) in mammalian cells. Radiat Res 2008; 170:784-93; PMID:19138034; http://dx.doi.org/10.1667/RR1375.1
37. Terasima T, Tolmach LJ. X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells. Science 1963; 140:490-2; PMID:13980636; http://dx.doi.org/10.1126/science.140.3566.490
38. Kagan VE, Tyurina YY. Recycling and redox cycling of phenolic antioxidants. Ann N Y Acad Sci 1998; 854:425-34; PMID:9928449; http://dx.doi.org/10.1111/j.1749-6632.1998.tb09921.x
39. Kensler T, Guyton K, Egner P, McCarthy T, Lesko S, Akman S. Role of reactive intermediates in tumor promotion and progression. Prog Clin Biol Res 1995; 391:103-16; PMID:8532709
40. Seo HR, Seo WD, Pyun BJ, Lee BW, Jin YB, Park KH, et al. Radiosensitization by celastrol is mediated by modification of antioxidant thiol molecules. Chem Biol Interact 2011; 193:34-42; PMID:21570383; http://dx.doi.org/10.1016/j.cbi.2011.04.009
41. Lee JH, Choi KJ, Seo WD, Jang SY, Kim M, Lee BW, et al. Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90. Int J Mol Med 2010; 27:441-6; PMID: 21249311
42. Liao HF, Kuo CD, Yang YC, Lin CP, Tai HC, Chen YY, et al. Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation. J Radiat Res (Tokyo) 2005; 46:387-93; PMID: 16394628; http://dx.doi.org/10.1269/jrr.46.387
43. Gurung RL, Lim SN, Khaw AK, Soon JF, Shenoy K, Mohamed Ali S, et al. Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS ONE 2010; 5:e12124; PMID:20711342; http://dx.doi.org/ 10.1371/journal.pone.0012124
44. Rietjens IM, Boersma MG, van der Woude H, Jeurissen SM, Schutte ME, Alink GM. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutat Res 2005; 574: 124-38; PMID:15914212; http://dx.doi.org/10.1016/j.mrfmmm.2005.01.028
45. Barreto G, Madureira D, Capani F, Aon-Bertolino L, Saraceno E, Alvarez-GiraldezLD.The role of catechols and free radicals in benzene toxicity: an oxidativeDNA damage pathway. Environ Mol Mutagen 2009; 50:771-80; PMID:19449395; http://dx.doi.org/10.1002/em.20500
46. Bentle MS, Bey EA, Dong Y, Reinicke KE, Boothman DA. New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors. J Mol Histol 2006; 37:203-18; PMID:16868862; http://dx.doi.org/10.1007/s10735-006-9043-8
47. Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, et al. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer 2010; 62:938-46; PMID:20924969; http://dx.doi.org/10.1080/01635581.2010.509832
48. Bolton JL, Thatcher GR. Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol 2008; 21:93-101; PMID:18052105; http://dx.doi.org/10.1021/tx700191p
49. Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 2009; 41:89-295; PMID:19514967; http://dx.doi.org/10.1080/03602530902843483
50. Samuni AM, Afeworki M, Stein W, Yordanov AT, DeGraff W, Krishna MC, et al. Multifunctional antioxidant activity of HBED iron chelator. Free Radic Biol Med 2001; 30:170-7; PMID:11163534; http://dx.doi.org/10.1016/S0891-5849(00) 00459-7